click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)


The IMF’s ”Living Well with Myeloma” quarterly teleconference series is designed to cover all the important and most up-to-date information regarding multiple myeloma.

This 60-minute question-and-answer session will discuss what patients need to know to overcome side effects from novel therapies. Speakers will be Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, of the Cleveland Clinic Taussig Cancer Institute, and Kevin Brigle, PhD, NP of the VCUHS Massey Cancer Center. 

This teleconference is sponsored by an educational grant from:
Amgen, Bristol-Myers Squibb, Celgene Corporation,  Janssen, and Takeda Oncology

Previous Post
Robin Tuohy's testimony at CEPAC on Treatment Options for Relapsed and Refractory Myeloma.
Next Post
BOCA PFS 2016 - Myeloma Fast Facts

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.